Brazil retail
| | | | | | | | | | | |
Alpha-glucosidase inhibitors
|
2.18
|
2.12
|
2.06
|
1.90
|
2.03
|
1.89
|
1.55
|
1.45
|
1.21
|
0.81
|
0.62
|
Biguanides
|
34.56
|
37.50
|
40.94
|
43.61
|
45.70
|
48.61
|
49.55
|
49.56
|
51.39
|
54.21
|
57.53
|
DPP4 inhibitors
|
0
|
0
|
0
|
0
|
0
|
0.77
|
2.25
|
2.70
|
2.48
|
2.43
|
2.77
|
Fixed dose combinations**
|
1.51
|
4.35
|
6.87
|
8.29
|
9.04
|
8.50
|
9.26
|
10.07
|
9.50
|
8.32
|
7.60
|
Non-sulfonylurea secretagogues
|
3.55
|
3.58
|
3.28
|
2.94
|
2.76
|
2.19
|
1.55
|
1.25
|
0.98
|
0.58
|
0.33
|
Thiazolidinediones
|
0.73
|
0.86
|
0.93
|
1.14
|
1.55
|
1.34
|
0.99
|
0.93
|
0.76
|
0.47
|
0.46
|
Sulfonylureas
|
57.48
|
51.60
|
45.93
|
42.12
|
38.92
|
36.70
|
34.85
|
34.04
|
33.68
|
33.19
|
30.69
|
China hospital
| | | | | | | | | | | |
Alpha-glucosidase inhibitors
|
10.50
|
13.48
|
16.65
|
18.41
|
19.76
|
21.06
|
21.95
|
23.16
|
25.48
|
26.94
|
27.35
|
Biguanides
|
45.41
|
43.48
|
39.27
|
38.03
|
37.34
|
36.57
|
35.68
|
34.31
|
32.93
|
33.22
|
34.64
|
DPP4 inhibitors
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0.01
|
0.06
|
0.15
|
Fixed dose combinations**
|
0
|
0
|
0
|
0
|
0
|
0.01
|
0.03
|
0.15
|
0.21
|
0.13
|
0.15
|
Non-sulfonylurea secretagogues
|
2.26
|
3.85
|
5.58
|
6.98
|
8.31
|
10.33
|
12.05
|
13.72
|
14.72
|
15.16
|
14.13
|
Thiazolidinediones
|
0.37
|
0.66
|
0.93
|
1.26
|
2.35
|
2.99
|
3.31
|
3.79
|
3.82
|
3.30
|
2.79
|
Sulfonylureas
|
41.45
|
38.54
|
37.56
|
35.32
|
32.24
|
29.04
|
26.98
|
24.88
|
22.83
|
21.19
|
20.80
|
Thailand hospital
| | | | | | | | | | | |
Alpha-glucosidase inhibitors
|
1.37
|
1.12
|
1.01
|
1.02
|
1.17
|
1.27
|
1.29
|
1.34
|
1.29
|
1.16
|
1.09
|
Biguanides
|
41.79
|
45.92
|
48.30
|
49.27
|
50.45
|
52.09
|
54.78
|
55.11
|
55.26
|
55.00
|
56.63
|
DPP4inhibitors
|
0
|
0
|
0
|
0
|
0
|
0
|
0.08
|
0.23
|
0.41
|
0.62
|
0.71
|
Fixed dose combinations**
|
0
|
0
|
0.01
|
0.05
|
0.08
|
0.12
|
0.20
|
0.31
|
0.40
|
0.49
|
0.68
|
Non-sulfonylurea secretagogues
|
0.15
|
0.15
|
0.14
|
0.14
|
0.16
|
0.17
|
0.16
|
0.16
|
0.15
|
0.14
|
0.15
|
Thiazolidinediones
|
0.43
|
0.54
|
0.71
|
0.81
|
1.18
|
1.28
|
1.38
|
1.61
|
1.90
|
2.15
|
2.33
|
Sulfonylureas
|
56.26
|
52.27
|
49.83
|
48.71
|
46.96
|
45.06
|
42.11
|
41.25
|
40.58
|
40.45
|
38.41
|
Thailand retail
| | | | | | | | | | | |
Alpha-glucosidase inhibitors
|
1.83
|
1.58
|
1.30
|
1.11
|
1.98
|
1.92
|
1.69
|
1.73
|
2.28
|
1.86
|
2.75
|
Biguanides
|
35.12
|
32.10
|
37.81
|
42.00
|
42.82
|
43.16
|
39.94
|
43.41
|
39.71
|
41.17
|
40.81
|
DPP4 inhibitors
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0.16
|
0.62
|
1.31
|
Fixed dose combinations**
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0.09
|
0.06
|
0.05
|
0.27
|
Non-sulfonylurea secretagogues
|
0
|
0
|
0.19
|
0.22
|
0.38
|
0.41
|
0.47
|
0.50
|
0.50
|
0.43
|
0.50
|
Thiazolidinediones
|
0.23
|
0.50
|
0.54
|
0.62
|
0.66
|
0.58
|
0.54
|
1.43
|
1.75
|
1.74
|
2.37
|
Sulfonylureas
|
62.82
|
65.82
|
60.16
|
56.06
|
54.16
|
53.93
|
57.35
|
52.83
|
55.54
|
54.12
|
52.00
|